Paloma Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,182
| Closed | -$579K | – | 2027 |
|
|
2020
Q4 | $579K | Buy |
+4,182
| New | +$579K | 0.02% | 649 |
|
|
2020
Q1 | – | Sell |
-18,746
| Closed | -$801K | – | 1653 |
|
|
2019
Q4 | $801K | Buy |
+18,746
| New | +$801K | 0.01% | 875 |
|
|
2018
Q4 | – | Sell |
-4,494
| Closed | -$343K | – | 1320 |
|
|
2018
Q3 | $343K | Buy |
+4,494
| New | +$343K | 0.01% | 902 |
|
|
2018
Q2 | – | Sell |
-10,095
| Closed | -$514K | – | 1566 |
|
|
2018
Q1 | $514K | Sell |
10,095
-2,401
| -19% | -$122K | 0.01% | 902 |
|
|
2017
Q4 | $580K | Buy |
+12,496
| New | +$580K | 0.01% | 732 |
|
|
2016
Q3 | – | Sell |
-7,398
| Closed | -$362K | – | 1577 |
|
|
2016
Q2 | $362K | Buy |
+7,398
| New | +$362K | ﹤0.01% | 1256 |
|